Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, April 22, 2015

Regeneus (ASX:RGS) Receives Approval For Progenza OA Trial

Regeneus , a clinical stage regenerative medicine company focused on the development of cell therapies, announced today that it has received ethics approval for a clinical trial of its new off-the-shelf allogeneic stem cell treatment, known as Progenza, for patients with knee osteoarthritis. Progenza is produced from adipose tissue from a healthy donor who has been extensively screened.
http://ift.tt/1HV4bDX

No comments:

Post a Comment

Popular Stem Cell Roundup Posts